82W.DU (Hims & Hers Health) is trading 4.7% down at $27.80. - This decline follows an announcement by rival LifeMD of an exclusive self-pay telehealth program for Xyosted testosterone injections, impacting Hims & Hers' market position. - The move extends a multi-day pullback, but today's specific catalyst is related to competitor activity rather than general market sentiment. - Broader market sentiment also shows some risk-off mood for growth stocks.